TY - JOUR
T1 - Angiogenesis in the human corpus luteum
T2 - Changes in expression of angiopoietins in the corpus luteum throughout the menstrual cycle and in early pregnancy
AU - Sugino, Norihiro
AU - Suzuki, Takashi
AU - Sakata, Aki
AU - Miwa, Ichiro
AU - Asada, Hiromi
AU - Taketani, Toshiaki
AU - Yamagata, Yoshiaki
AU - Tamura, Hiroshi
PY - 2005/11
Y1 - 2005/11
N2 - Context: Blood vessel stabilization is regulated by angiopoietins and important for angiogenesis in the corpus luteum. Objective: To study angiogenesis and blood vessel stabilization in the human corpus luteum, changes in expression of angiopoietin (Ang)-1, Ang-2, and their specific receptor, Tie-2, together with the number of blood vessels and pericytes were examined in the corpus luteum throughout the menstrual cycle and in early pregnancy. Design: The number of blood vessels and pericytes was determined by immunohistochemistry for CD34 and α-smooth muscle actin, respectively. Ang and Tie-2 expression were examined by immunohistochemistry or RT-PCR. Results: The number of blood vessels increased during the early luteal phase, whereas the number of pericytes was small in the early luteal phase and increased in the midluteal phase, suggesting that angiogenesis is undergoing during the early luteal phase and blood vessels are stabilized in the midluteal phase. Blood vessels and pericytes decreased in number during the late luteal phase. The increased number of both blood vessels and pericytes seen in the corpus luteum of early pregnancy suggests that angiogenesis is undergoing accompanied by blood vessel stabilization. Ang-2 expression with low Ang-1 expression was found during the early luteal phase. Thereafter, increasing Ang-1 expression during the midluteal phase, declining Ang-1 expression with continued Ang-2 expression during the late luteal phase, and relatively high Ang-1 expression in early pregnancy were observed. Conclusions: The change in Ang expression is closely associated with angiogenesis, blood vessel stabilization, and blood vessel regression during the divergent phases of luteal formation, luteal regression, and luteal rescue by pregnancy.
AB - Context: Blood vessel stabilization is regulated by angiopoietins and important for angiogenesis in the corpus luteum. Objective: To study angiogenesis and blood vessel stabilization in the human corpus luteum, changes in expression of angiopoietin (Ang)-1, Ang-2, and their specific receptor, Tie-2, together with the number of blood vessels and pericytes were examined in the corpus luteum throughout the menstrual cycle and in early pregnancy. Design: The number of blood vessels and pericytes was determined by immunohistochemistry for CD34 and α-smooth muscle actin, respectively. Ang and Tie-2 expression were examined by immunohistochemistry or RT-PCR. Results: The number of blood vessels increased during the early luteal phase, whereas the number of pericytes was small in the early luteal phase and increased in the midluteal phase, suggesting that angiogenesis is undergoing during the early luteal phase and blood vessels are stabilized in the midluteal phase. Blood vessels and pericytes decreased in number during the late luteal phase. The increased number of both blood vessels and pericytes seen in the corpus luteum of early pregnancy suggests that angiogenesis is undergoing accompanied by blood vessel stabilization. Ang-2 expression with low Ang-1 expression was found during the early luteal phase. Thereafter, increasing Ang-1 expression during the midluteal phase, declining Ang-1 expression with continued Ang-2 expression during the late luteal phase, and relatively high Ang-1 expression in early pregnancy were observed. Conclusions: The change in Ang expression is closely associated with angiogenesis, blood vessel stabilization, and blood vessel regression during the divergent phases of luteal formation, luteal regression, and luteal rescue by pregnancy.
UR - http://www.scopus.com/inward/record.url?scp=27744598168&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=27744598168&partnerID=8YFLogxK
U2 - 10.1210/jc.2005-0643
DO - 10.1210/jc.2005-0643
M3 - Article
C2 - 16118339
AN - SCOPUS:27744598168
VL - 90
SP - 6141
EP - 6148
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
SN - 0021-972X
IS - 11
ER -